Abstract
Hypertension is associated with cardiac noradrenergic hyperactivity, although it is not clear if this precedes or follows the development of hypertension itself. We hypothesized that Ca2+ homeostasis in postganglionic sympathetic neurons is impaired in spontaneously hypertensive rats (SHR), and may occur before the development of hypertension. The depolarization induced rise in intracellular free calcium concentration ([Ca2+]i) (measured using fura-2/AM) was significantly larger in cultured sympathetic neurons from pre-hypertensive SHR’s than in age matched normotensive Wistar-Kyoto (WKY) rats. The decay of the [Ca2+]i transient was also faster in SHRs. The endoplasmic reticulum Ca2+ content and caffeine induced [Ca2+]i amplitude were significantly greater in the young SHR. Lower protein levels of phospholamban and more copies of ryanodine receptor mRNA were also observed in the young SHR. Depleting the endoplasmic reticulum Ca2+ store did not alter the difference of the evoked [Ca2+]i transient and decay time between young SHR and WKY. However, removing mitochondrial Ca2+ buffering abolished these differences. A lower mitochondrial membrane potential was also observed in young SHR sympathetic neurons. This resulted in impaired mitochondrial Ca2+ uptake and release which might partly be responsible for the increased [Ca2+]i transient and faster decay in SHR sympathetic neurons. This Ca2+ phenotype seen in early development in cardiac stellate and superior cervical ganglion neurons may contribute to the sympathetic hyper-responsiveness that precedes the onset of hypertension.
Keywords: Hypertension, Sympathetic neuron, Calcium homeostasis, endoplasmic reticulum, mitochondria
Hypertension is a multi organ disease involving the kidney, vasculature, and autonomic nervous system. In particular, abnormal neurohumoral activation is a hallmark of hypertension and is a negative prognostic indicator for sudden cardiac death and a strong independent predictor of mortality1, 2. Much evidence supports the observation that sympathetic hyper-responsiveness is involved in the pathophysiology of human and animal primary hypertension3-5. Increases in muscle sympathetic nerve activity in response to mental stress has been documented in normotensive offspring linked to a family history of hypertension6. This suggests that dysregulated sympatho-humoral activation may be an early marker of hypertension in those that are genetically predisposed to the disease.
Intracellular calcium concentration ([Ca2+]i) plays a pivotal role in triggering neurotransmitter release from sympathetic neurons7. In superior cervical ganglion (SCG) neurons, Ca2+ signals govern the release of norepinephrine (NE)8, 9. In turn, NE release plays a critical role in the regulation of blood pressure and cerebral blood flow distribution10, 11. We have shown in the spontaneously hypertensive rat (SHR), enhanced heart rate responses and evoked NE release from the post-ganglionic neurons innervating the heart when compared to normotensive Wistar Kyoto (WKY) rats12, 13. Post synaptically, basal and NE-stimulated L-type calcium current (ICaL) in single sino-atrial node cells was also enhanced in the SHR, as was the heart rate response to bath applied NE14. Taken together, these results suggest a significant component of the sympathetic hyper-responsiveness in the SHR occurs at the end organ level.
We tested the hypothesis that intracellular Ca2+ homeostasis is dysregulated in the SHR, and that this is genetically programmed and precedes the subsequent development of hypertension. To investigate the mechanisms involved in the potential differences between the SHR and WKY rat, we targeted calcium handling by the endoplasmic reticulum (ER) and mitochondria in an attempt to delineate whether disruption of Ca2+ handling proteins in intracellular stores might explain the enhanced exocytotic response in the SHR12, 15.
Methods
Animals
Neonatal (4-7 days), pre-hypertensive young (4-6 weeks) and hypertensive adult (15-17 weeks old) male SHRs and WKY rats were used in this study. Cells were isolated from the SCG and cardiac stellate ganglion for phenotyping. The investigation conformed to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996) and the Animals (Scientific Procedures) Act 1986 (UK).
An expanded Materials and Methods section is available in the online data supplement at http://hyper.ahajournals.org.
Results
Animal characteristics
The phenotypical characteristics of both young and adult SHRs and WKY rats are summarized in Supplement table S1. No differences in ventricular weight / body weight ratio (an indication of left ventricular hypertrophy), mean arterial blood pressure or heart rate measured in- vivo were observed in the young SHRs, whereas these measures were significantly increased in the adult SHRs when compared to the age matched WKY rats.
Intracellular free calcium transients in sympathetic neurons
Sympathetic neurons were confirmed by the catecholamine neuronal marker anti-Tyrosine Hydroxylase stain (Fig. 1A). Intracellular calcium concentration was performed by ratiometric recordings in single sympathetic neurons (Fig. 1B). A typical calcium intensity profile of a sympathetic neuron responding to 100 mmol/L KCl was shown in Fig. 1C. In the SHR, high K+ evoked [Ca2+]i was significantly enhanced in both stellate ganglion (Fig. 2) and SCG neurons (Fig. 3A,B) when compared with age matched WKY rats. In depth profiling of the neural phenotype was performed on SCG cells because of the higher yield of neurons and ease of dissection.
Figure 1.
A: Fluorescence images of sympathetic neurons derived from SCG which were stained with the adrenergic marker anti-Tyrosine Hydroxylase (Texas-red) and the nuclear marker DAPI (blue). B: Pseudo-color-coded ratio-images of Fura-2 loaded SCG neuron were obtained by conventional fluorescence microscopy. Ca2+ concentrations were color-coded with a basal Ca2+ concentration in blue and a high Ca2+ concentration in red. C: An example recording from young WKY single SCG neuron exposed to 100 mmol/L KCl (30 sec) to depolarize the neuron resulting in [Ca2+]i increase. The peak evoked [Ca2+]i was absent in the extracellular Ca2+ free solution.
Figure 2.

A: An example recording from young SHR & WKY cardiac sympathetic neuron taken from stellate ganglion exposed to 100 mmol/L KCl for 30 sec to depolarize the neuron and evoke voltage-gated Ca2+ entry. B: Statistical data showing the difference in peak evoked [Ca2+]i increase between young SHR & WKY. *p<0.05, t-test.
Figure 3.
A: Typical fluorescence ratio profile of single SCG neurons following exposure to high KCl. B: Statistical data showed peak increase in [Ca2+]i upon high K+ exposure from SHRs compared with WKY rats of the same age. C: Time taken for the [Ca2+]i from peak to 50% & 10% of the increase (triangle, 50%& circles, 90%decay time) following high K+ challenge. * p<0.05, **p<0.01; t-test. † p < 0.05, †† p<0.01; one way ANOVA.
Baseline [Ca2+]i was significantly higher in SCG neurons from the SHRs when compared with age matched WKY rats in all three age groups (Supplement table S2). The baseline [Ca2+]i in the SHR decreased with age, whereas this was not seen in the WKY. During depolarization with high K+, SCG neurons from the neonatal SHR had a greater increase in [Ca2+]i when compared to those from the WKY (Fig. 3A,B). This effect was present in animals of all age groups from neonatal to adult rats. There was a significant increase in evoked [Ca2+]i between the young and adult SHRs (Fig. 3B). SCG neurons from the WKY also showed an increase in depolarization evoked [Ca2+]i with age, but the response remained smaller than the SHR (eg. at adult, SHR +32.10%, WKY +13.92% compared with young rats, Fig. 3B). We also calculated the area under the curve of the Ca2+ response to high K+ (Supplement Figure S1), and observed that this was significantly greater in the SHR from neonatal to the fully developed hypertensive rat when compared with the age matched WKY. Analyzing the responses as a % change from baseline also resulted in a greater [Ca2+]i responses in the young SHR, although this was not observed in the neonatal or adult rats (Supplement table 3).
Increased rate and decay time of the calcium transient in SCG neurons
In both SHR and WKY rats, the [Ca2+]i increased rapidly in response to high K+ and fell slowly upon high K+ removal (Fig. 3A). The rate of rise (Δratio/Δtime) increased with age (Supplement table S4), but there was no significant difference between SHR and WKY rats in any age group. The WKY group demonstrated a significantly longer (50% and 90%) decay time in comparison to the SHR group from young and adult rats (Fig. 3C). Since clear differences in both the amplitude and decay time of the [Ca2+]i were apparent in young prehypertensive SHR and WKY rats, further experiments to investigate the role of the endoplasmic reticulum and mitochondria focused on young rats (4 weeks old).
Endoplasmic reticulum calcium handling in SCG neurons
Monitoring of ER Ca2+ concentration
Ca2+ concentration in the ER can be directly measured by monitoring the Ca2+ within the organelles after loading with a low affinity Ca2+ indicator mag-fura-2/AM (Supplement Figure S2). Baseline mag-fura-2/AM fluorescence ratios were significantly higher in sympathetic neurons of young SHR when compared with WKY (Fig. 4A left group bar). This difference persisted when the suffusate had zero calcium present (Fig. 4A right group bar & 4B). Activation of ryanodine receptors (RyRs) and depletion of Ca2+ from ER stores with 10 mmol/L caffeine produced a larger drop in the mag-fura-2 fluorescence ratio in the SHR (−7.05 ± 1.14%) compared with the WKY (−2.58 ± 0.68%) (p<0.01, Fig. 4B). Subsequent introduction of the cell-permeant intraluminal Ca2+/heavy metal chelator, N,N,N′,N′-tetrakis(2-pyridylmethyl)-ethylenediamine (TPEN), caused a further reduction in the mag-fura-2 fluorescence ratio in both groups (Fig. 4B). Fluorescence ratio normalized by baseline showed that the caffeine evoked changes in ER Ca2+ was significantly greater in the SHR than the WKY rats (to 0.92 ± 0.01 vs 0.96 ± 0.01, p<0.01, Fig. 4C), whilst the TPEN response was similar (to 0.82 ± 0.03 vs 0.85 ± 0.03, p=0.51, Fig. 4C). Releasable ER Ca2+ load was also estimated based on the [Ca2+]i responses to caffeine (10 mmol/L, 30 sec, Fig. 4D).
Figure 4. Enhanced ER calcium load in SCG neurons in the young prehypertensive SHR.
A: Direct measurement of resting ER Ca2+ concentration using mag-fura-2/AM. B: ER Ca2+ depleted with caffeine followed by TPEN. C: Normalization of ratio by baseline. D: Caffeine evoked Ca2+ release from the ER (measured using fura-2/AM) was significantly higher in SHRs either in normal or zero calcium solution. The inset is an example of the fluorescence ratio in the SCG neurons in response to 10 mmol/L caffeine for 30 seconds. E: The SCG from the SHR has significantly more copies of ryanodine receptor (RyR3) mRNA after 46 cycles of semi-quantitative RT-PCR when compared with the WKY (n=8 SCGs per group). *p<0.05, **p<0.01, t- test, SHR compared with WKY.
The ryanodine receptor
Studies have shown that advancing age can selectively change the genetic expression and protein levels of RyR3, but not RyR2 and RyR1 isoforms in the SCG aged 6, 12 and 24 months rats16. Therefore, we investigated whether the RyR3 receptor is altered in young SHR. Western blots were not sensitive enough to detect RyR3 receptor protein in the SCG dissected from young rats. However, SHRs were found to have significantly more RyR3 mRNA copies than WKY rats using RT-PCR (Fig. 4E).
Protein expression of sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) and Phospholamban (PLN)
To understand the mechanism underlying the faster [Ca2+]i decay in the SHR, western blot analyses were performed to assess the expression levels of SERCA2a and PLN in SCG homogenates from young WKY and SHRs (Fig. 5). SERCA pump is under the regulatory control of the phosphoprotein phospholamban, which inhibits the apparent affinity of SERCA for Ca2+ in its non phosphorylated form17. There was no difference in protein level of SERCA2a from young SHRs and WKY rats (p=0.63, Fig. 5B). However, both the total as well as the phosphorylated portion (PLN-Ser16) of the PLN were significantly lower in the SHR group (Fig. 5C, D). There was no difference in the PLN-Thr17 between the two groups (data not shown).
Figure 5.
A: Representative immunoblots using antibodies specific for SERCA2a, total PLN, Ser16-phosphorylated PLN and GAPDH (as a loading control), using SCG homogenates from young SHRs and WKY rats. Equal amounts of protein were loaded in each line. B, C, D: Bar graphs showing protein level of SERCA2a, total PLN and Ser16-phosphorylated PLN contents from the young SHRs and WKY rats (n=10 SCGs per group, *p<0.05, t-test).
ER contribution to the changes [Ca2+]i in the SHR
To evaluate the contribution of the ER to the differences in peak [Ca2+]i rise and recovery time, ER Ca2+ stores were depleted by using caffeine (10 mmol/L, 30 sec), and Ca2+ reuptake from SERCA pumps were blocked with 1 μmol/L Thapsigargin. Caffeine was re-introduced at 8.5min and 13.5min to confirm ER Ca2+ depletion (Fig. 6A). Under these conditions, the SHR group continued to have a significantly higher elevation of [Ca2+]i during high K+ depolarization when compared with the WKY group (Fig 6B). The baseline [Ca2+]i was increased by 0.157 ± 0.028 μmol/L in the SHR and 0.136 ± 0.021 μmol/L in the WKY after ER Ca2+ depletion (p=0.56, t-test). Because 90% decay time for the second high K+ depolarization was not reached in some experiments, only 50% decay time was measured and this remained significantly shorter in the SHR when compared with the WKY group (p<0.01, Fig. 6C).
Figure 6.
A: Typical experimental protocol presenting fluorescence ratio of Fura-2/AM to assess the contribution of the ER to the increase in [Ca2+]i upon high KCl exposure in the young WKY rats. B: Statistical data showing the peak evoked [Ca2+]i transient both before (S1) and after (S2) ER Ca2+ store depletion between young SHR and WKY. C: The difference between SHR and WKY in regards to 50% decay time before (S1) and after (S2) ER Ca2+ store depletion. Caff – caffeine, Thap – thapsigargin. *p<0.05, **p<0.01, t-test.
Mitochondrial calcium in SCG neurons
Mitochondria contribution to the [Ca2+]i
The proton uncoupler FCCP (carbonylcyanide-p-trifluoromethoxyphenylhydrazone, 1 μmol/L) causes an immediate depolarization of the inner mitochondrial membrane, resulting in depletion of stored mitochondrial Ca2+ and inhibition of any further mitochondrial Ca2+-uptake18. Application of FCCP produced a small transient rise in [Ca2+]i (Fig. 7A, center). This increase was not different between the two strains (SHR: 189 ± 10 vs WKY: 198 ± 10 nmol/L, p=0.55, t-test, n=17 and 23 respectively). Subsequent exposure to high K+ in the continued presence of FCCP resulted in an increase in the amplitude of the [Ca2+]i transient of 23.15 ± 1.78 % in the WKY and 12.74 ± 2.48% in the SHR (p<0.01, t-test, Fig. 7B), abolishing the difference in depolarization induced [Ca2+]i increase between the two groups. The 50% & 90% decay time of the [Ca2+]i transient were significantly shortened by FCCP in both WKY and SHR neurons (p<0.001, ANOVA), and the difference in 50% & 90% decay time between SHR and WKY were abolished (Fig. 7C).
Figure 7.
A: Typical experimental protocol showing Fura-2/AM fluorescence ratio to assess the contribution of mitochondria to [Ca2+]i in SCG neurons from young SHR and WKY rats. B: Statistical data showing the peak evoked [Ca2+]i both before (S1) and after (S2) mitochondrial Ca2+ store depletion with FCCP between young SHR & WKY rats. C: Time taken for the [Ca2+]i from peak to 50% & 10% of the increase (triangle, 50% & circles, 90% decay time) following high K+ challenge. *p<0.05, **p<0.01, ***p<0.001.
Measurement of the mitochondria membrane potential in sympathetic neurons
We then measured the membrane potential of mitochondria (ΔΨm) using a fluorescent dye tetra-methylrhodamine ethyl ester (TMRE, 20 nmol/L, 5min). We confirmed that TMRE uptake was indeed due to accumulation within the mitochondria by demonstrating that it was rapidly released upon mitochondrial depolarization with FCCP (Fig 8B). TMRE-fluorescence intensity was significantly higher in the WKY than in the SHR (Fig. 8A&B, p<0.001, t-test).
Figure 8.

A: Comparison of the mitochondria membrane potential (ΔΨm) using the fluorescence indicator TMRE in SCG neurons from young SHR (right) and WKY (left). B: Changes in TMRE intensity at resting state and during superfusion of 2 μmol/L FCCP in two groups of neurons. * p<0.001, t-test.
Discussion
There are three novel findings from this study. First, sympathetic neurons from the SHR have a significantly greater depolarization evoked [Ca2+]i transient when compared with the age matched WKY. This difference persisted from neonates through to young prehypertensive and fully developed adult hypertensive animals. Furthermore, the rate of decay of [Ca2+]i was faster in young and adult SHR. Secondly, increased ER Ca2+ content, upregulated SERCA (due to reduced PLN inhibition) and ryanodine receptor activity were seen in the young SHR. Thirdly, mitochondrial membrane potential was reduced in the young SHR sympathetic neurons, and this may contribute to the differences in depolarization evoked [Ca2+]i transients and the rate of decay between the two groups. When all results are taken together, they suggest that alteration of [Ca2+]i in sympathetic neurons from the SCG cells (and by extrapolation, stellate ganglion cells), precedes the actual onset of hypertension, and thereby maybe responsible for the enhanced sympathetic responsiveness seen at this developmental stage.
Intracellular free calcium transients in the SHR
Calcium is an important ubiquitous secondary signaling messenger that is involved in both short term as well as long term regulation of cell function, metabolism and growth19, 20. In neurons, an increase in [Ca2+]i forms the pivotal link between the action potential and neurotransmitter release7, 21. It is well established that hypertension is strongly associated with noradrenergic hyperactivity, with increased central sympathetic output as well as elevated plasma epinephrine and NE levels22, 23. This dysregulation occurs at several levels of the cardiovascular neural axis, where peripheral sympathetic hyper-responsiveness in the adult hypertensive rat results in enhanced evoked cardiac NE release12, 15 and also increased β adrenergic responses in myocytes24. Abnormal calcium handling properties have been reported in SHR vascular smooth muscle cells25 and endothelial cells26, and it is conceivable that this also occurs in sympathetic neurons, thus providing a possible molecular link to enhanced noradrenergic neurotransmission.
The resting [Ca2+]i level in the SCG neurons from the neonates through to fully developed hypertensive animals was higher than that observed in the age matched WKY rat. Similarly the [Ca2+]i handling expressed as a percentage change from baseline was also greater in the young SHR. However, this was not evident in the neonatal or adult cells from the SHR, and may be related to poor statistical power. Nevertheless, when taken together with the absolute [Ca2+]i responses and the area under the curve measurement for [Ca2+]i (Fig. S1), the data are consistent with the hypothesis that pre-hypertensive SHRs have abnormal [Ca2+]i handling properties compared to age matched WKY animals. The overall magnitude of the evoked [Ca2+]i transient increased with age in both groups, and the increase in the SHR group was larger, thus maintaining a difference between the two groups. This supports the idea that abnormal calcium regulation occurs early before hypertension takes place, but that age alone does not fully explain the development of the calcium phenotype in the SHR when compared to the WKY.
The higher depolarization evoked [Ca2+]i was not selective for SCG which predominately provide sympathetic innervation to the neck and cranial tissue27, but it was also seen in neurons from the stellate ganglion that have a significant innervation into the heart. These data may at least partially explain why there is an increased local cardiac noradrenergic neurotransmission in the adult SHR when compared with the WKY12, 15. Moreover, emerging evidence has demonstrated enhanced NE release and heart rate responses to cardiac sympathetic activation in young pre-hypertensive SHR’s in-vitro28.
Evoked [Ca2+]i responses are influenced by multiple factors, including Ca2+ entry, extrusion across the plasma membrane, Ca2+ uptake and release from internal stores, and endogenous and exogenous Ca2+ buffering. From our results, there was no significant difference in the rate of rise of the [Ca2+]i transient in response to K+ induced depolarization between SHR and WKY rats in all age groups. This suggests that the depolarization induced Ca2+ entry through the plasma membrane was not different in sympathetic neurons from the SHR compared to the WKY at any age. However, we did not measure the membrane calcium current directly, so cannot completely exclude some involvement of plasma membrane bound Ca2+ channels.
Endoplasmic reticulum calcium signaling in the SHR
Increasing evidence suggests that altered ER Ca2+ uptake, storage, and release plays a central role in cardiac hypertrophy and heart failure29. In the present study, before neurons were re-exposed to high KCl, ER Ca2+ stores were depleted by caffeine and Ca2+ reuptake from SERCA pumps were prevented by thapsigargin. Under these conditions, the increased [Ca2+]i should represent a non-ER contribution. We found that the SHR group continued to have a higher increase in depolarization evoked [Ca2+]i even after ER Ca2+ depletion. This result suggests that the non-ER sources may underlie the significantly higher depolarization evoked [Ca2+]i transients seen in the SHR.
The larger ER Ca2+ store in the SHR was confirmed by directly measuring ER free Ca2+ concentration using mag-fura-2/AM, followed by ER Ca2+ release/depletion with caffeine and the ER-Ca2+ chelator, TPEN. This finding itself does not necessarily indicate a larger ER contribution towards depolarization evoked [Ca2+]i in the SHR, since the net ER contribution depends on the relative release and re-uptake of Ca2+ by the ER30, 31. It does however, imply a larger ER Ca2+ store that is potentially available for release upon appropriate stimulation.
The rate at which SERCA moves Ca2+ across the ER membrane can be reduced by PLN, whereas phosphorylation of the PLN relieves its inhibition32, 33. Our results showed that the difference in total PLN was much larger than the difference in PLN-Ser16, suggesting that there was less non-phosphorylated PLN in the SHR than WKY, and therefore less PLN dependent inhibition of SERCA activity in the pre-hypertensive SHR. This is in keeping with the functional data showing shorter 50% and 90% decay times in [Ca2+]i.
Ryanodine receptors are Ca2+ permeable channels that open in responses to increase in [Ca2+]i34. We introduced the RyR activator caffeine to deplete Ca2+ from ER stores. Prehypertensive SHRs had a significantly higher caffeine induced [Ca2+]i amplitude when compared with the age matched WKY, indicating that RyRs in sympathetic neurons were up regulated in the young SHR. This was confirmed by more copies of RyR3 mRNA in the SHR. These data are consistent with observations by others in cardiac myocytes35. Taken together, these findings suggest that sympathetic neurons from prehypertensive SHR have more active/dynamic ER Ca2+ handling machinery.
Mitochondrial calcium signaling in the SHR
Mitochondria take up Ca2+ primarily through the mitochondrial calcium uniporter36, which is modulated by both [Ca2+]i and the mitochondrial membrane potential (ΔΨm).37 The uniporter transports Ca2+ down the electrochemical gradient and this gradient is maintained across the mitochondrial inner membrane without direct coupling to ATP hydrolysis or transport of other ions. In this study we found that TMRE uptake was reduced in the SHR neurons which suggests that the membrane potential of mitochondria (ΔΨm) was more depolarized in the SHR. Depolarization of ΔΨm could lead to a reduced Ca2+ uptake by the mitochondria in the SHR.
A significant association of hypertension with mitochondrial uncoupling proteins (UCPs) has been reported both in experimental38 and human hypertensive states39. Moreover, in experimental hypertension, a decreased activity of complex IV has been observed in the hypertrophied myocardium from the SHRs40. However, we could not find any differences in protein levels of mitochondrial UCP2, citrate synthase (used as a quantitative enzyme marker for the presence of intact mitochondria) and complexes I-V in SCG homogenates from young SHRs and WKY rats (Supplement Figure S3). This indicates that mitochondrial number and the electron transport chain were not changed in young SHRs. The differences in depolarization evoked [Ca2+]i transient and the 50% & 90% decay time between SHR and WKY were abolished by application of the proton uncoupler FCCP. These results suggest that mitochondria play a major role in the depolarization evoked [Ca2+]i difference observed between the SHR and the WKY groups. Although we have no direct proof to show whether the ER and mitochondria contributed to the differences with age in [Ca2+]i transients in the SHR, our results are supportive of this idea when taken together with others41, 42 that showed an age-related decline in SERCA function with a subsequent increased reliance on mitochondria to control high K+-evoked [Ca2+]i transients.
Perspectives
Results from this study suggest that the difference in Ca2+ homeostasis between sympathetic neurons of SHR and WKY occurs early in the development, and before the actual onset of hypertension itself. Impairment of [Ca2+]i handling was observed at two neural sites in the sympathetic nervous system, suggesting that this impairment may be wide spread. A close link between faulty mitochondria Ca2+ release and re-uptake appears to be central to the enhanced [Ca2+]i transients observed in pre-hypertensive SHR’s. The precise molecular pathway underpinning this is not firmly established, but warrants further investigation. Moreover, it would be desirable to see whether the changes we report here are also seen in other animal models of hypertension. When all observations are viewed together with the current data, there is compelling evidence to suggest that alterations of Ca2+ homeostasis are central to sympathetic hyperactivity in the SHR, resulting in enhanced sympathetic neurotransmission at the end organ. The resultant chronotropic and inotropic action of NE will contribute to raising cardiac output and arterial blood pressure. These pathways may be important targets to prevent sympathetic dysregulation that occur before the onset of hypertension
Supplementary Material
Acknowledgments
We thank Prof. Sergey Kasparov and Dr. Haibo Xu for providing neonatal SHRs, Dr. Lisa Heather for her kind donation of primary antibody. Thanks to Dr. Mary McMenamin, Julia Shanks, Chieh-ju Lu, Kate Wannop for technical assistance.
Sources of Funding
This work was supported by a project grant from the British Heart Foundation and The Wellcome Trust OXION initiative. NH/DJP acknowledges additional support from the BHF Centre of Research Excellence, Oxford.
Footnotes
Disclosures
None.
Author Disclosures
Dan Li: No disclosures
Chee-wan Lee: No disclosures
Keith Buckler: No disclosures
Anant Parekh: No disclosures
Neil Herring: No disclosures
David J. Paterson: No disclosures
This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
References
- 1.Ramchandra R, Hood SG, Denton DA, Woods RL, McKinley MJ, McAllen RM, May CN. Basis for the preferential activation of cardiac sympathetic nerve activity in heart failure. Proc Natl Acad Sci U S A. 2009;106:924–928. doi: 10.1073/pnas.0811929106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Grassi G, Dell’Oro R, Seravalle G, Foglia G, Trevano FQ, Mancia G. Short- and long-term neuroadrenergic effects of moderate dietary sodium restriction in essential hypertension. Circulation. 2002;106:1957–1961. doi: 10.1161/01.cir.0000033519.45615.c7. [DOI] [PubMed] [Google Scholar]
- 3.Velez-Roa S, Ciarka A, Najem B, Vachiery JL, Naeije R, van de Borne P. Increased sympathetic nerve activity in pulmonary artery hypertension. Circulation. 2004;110:1308–1312. doi: 10.1161/01.CIR.0000140724.90898.D3. [DOI] [PubMed] [Google Scholar]
- 4.Flaa A, Mundal HH, Eide I, Kjeldsen S, Rostrup M. Sympathetic activity and cardiovascular risk factors in young men in the low, normal, and high blood pressure ranges. Hypertension. 2006;47:396–402. doi: 10.1161/01.HYP.0000203952.27988.79. [DOI] [PubMed] [Google Scholar]
- 5.Fisher LD, Tucker DC. Air jet noise exposure rapidly increases blood pressure in young borderline hypertensive rats. J Hypertens. 1991;9:275–282. doi: 10.1097/00004872-199103000-00012. [DOI] [PubMed] [Google Scholar]
- 6.Noll G, Wenzel RR, Schneider M, Oesch V, Binggeli C, Shaw S, Weidmann P, Luscher TF. Increased activation of sympathetic nervous system and endothelin by mental stress in normotensive offspring of hypertensive parents. Circulation. 1996;93:866–869. doi: 10.1161/01.cir.93.5.866. [DOI] [PubMed] [Google Scholar]
- 7.Neher E, Sakaba T. Multiple roles of calcium ions in the regulation of neurotransmitter release. Neuron. 2008;59:861–872. doi: 10.1016/j.neuron.2008.08.019. [DOI] [PubMed] [Google Scholar]
- 8.Rittenhouse AR, Zigmond RE. Role of N- and L-type calcium channels in depolarization-induced activation of tyrosine hydroxylase and release of norepinephrine by sympathetic cell bodies and nerve terminals. J Neurobiol. 1999;40:137–148. doi: 10.1002/(sici)1097-4695(199908)40:2<137::aid-neu1>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
- 9.Buchholz JN, Behringer EJ, Pottorf WJ, Pearce WJ, Vanterpool CK. Age-dependent changes in Ca2+ homeostasis in peripheral neurones: Implications for changes in function. Aging Cell. 2007;6:285–296. doi: 10.1111/j.1474-9726.2007.00298.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Cassaglia PA, Griffiths RI, Walker AM. Sympathetic nerve activity in the superior cervical ganglia increases in response to imposed increases in arterial pressure. Am J Physiol Regul Integr Comp Physiol. 2008;294:R1255–1261. doi: 10.1152/ajpregu.00332.2007. [DOI] [PubMed] [Google Scholar]
- 11.Wagerle LC, Heffernan TM, Sacks LM, Delivoria-Papadopoulos M. Sympathetic effect on cerebral blood flow regulation in hypoxic newborn lambs. Am J Physiol. 1983;245:H487–494. doi: 10.1152/ajpheart.1983.245.3.H487. [DOI] [PubMed] [Google Scholar]
- 12.Li D, Wang L, Lee CW, Dawson TA, Paterson DJ. Noradrenergic cell specific gene transfer with neuronal nitric oxide synthase reduces cardiac sympathetic neurotransmission in hypertensive rats. Hypertension. 2007;50:69–74. doi: 10.1161/HYPERTENSIONAHA.107.088591. [DOI] [PubMed] [Google Scholar]
- 13.Herring N, Lee CW, Sunderland N, Wright K, Paterson DJ. Pravastatin normalises peripheral cardiac sympathetic hyperactivity in the spontaneously hypertensive rat. J Mol Cell Cardiol. 2011;50:99–106. doi: 10.1016/j.yjmcc.2010.09.025. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Heaton DA, Lei M, Li D, Golding S, Dawson TA, Mohan RM, Paterson DJ. Remodeling of the cardiac pacemaker L-type calcium current and its beta-adrenergic responsiveness in hypertension after neuronal NO synthase gene transfer. Hypertension. 2006;48:443–452. doi: 10.1161/01.HYP.0000233383.04280.3c. [DOI] [PubMed] [Google Scholar]
- 15.Lee CW, Li D, Channon KM, Paterson DJ. L-arginine supplementation reduces cardiac noradrenergic neurotransmission in spontaneously hypertensive rats. J Mol Cell Cardiol. 2009;47:149–155. doi: 10.1016/j.yjmcc.2009.03.023. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Vanterpool CK, Vanterpool EA, Pearce WJ, Buchholz JN. Advancing age alters the expression of the ryanodine receptor 3 isoform in adult rat superior cervical ganglia. J Appl Physiol. 2006;101:392–400. doi: 10.1152/japplphysiol.00167.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Frank K, Kranias EG. Phospholamban and cardiac contractility. Ann Med. 2000;32:572–578. doi: 10.3109/07853890008998837. [DOI] [PubMed] [Google Scholar]
- 18.Antigny F, Girardin N, Raveau D, Frieden M, Becq F, Vandebrouck C. Dysfunction of mitochondria Ca2+ uptake in cystic fibrosis airway epithelial cells. Mitochondrion. 2009;9:232–241. doi: 10.1016/j.mito.2009.02.003. [DOI] [PubMed] [Google Scholar]
- 19.Clapham DE. Calcium signaling. Cell. 2007;131:1047–1058. doi: 10.1016/j.cell.2007.11.028. [DOI] [PubMed] [Google Scholar]
- 20.Carafoli E. Calcium-mediated cellular signals: A story of failures. Trends Biochem Sci. 2004;29:371–379. doi: 10.1016/j.tibs.2004.05.006. [DOI] [PubMed] [Google Scholar]
- 21.Schneggenburger R, Neher E. Presynaptic calcium and control of vesicle fusion. Curr Opin Neurobiol. 2005;15:266–274. doi: 10.1016/j.conb.2005.05.006. [DOI] [PubMed] [Google Scholar]
- 22.Greenwood JP, Stoker JB, Mary DA. Single-unit sympathetic discharge : Quantitative assessment in human hypertensive disease. Circulation. 1999;100:1305–1310. doi: 10.1161/01.cir.100.12.1305. [DOI] [PubMed] [Google Scholar]
- 23.Goldstein DS. Plasma catecholamines and essential hypertension. An analytical review. Hypertension. 1983;5:86–99. doi: 10.1161/01.hyp.5.1.86. [DOI] [PubMed] [Google Scholar]
- 24.Harzheim D, Movassagh M, Foo RS, Ritter O, Tashfeen A, Conway SJ, Bootman MD, Roderick HL. Increased InsP3Rs in the junctional sarcoplasmic reticulum augment Ca2+ transients and arrhythmias associated with cardiac hypertrophy. Proc Natl Acad Sci U S A. 2009;106:11406–11411. doi: 10.1073/pnas.0905485106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Sugiyama T, Yoshizumi M, Takaku F, Yazaki Y. Abnormal calcium handling in vascular smooth muscle cells of spontaneously hypertensive rats. J Hypertens. 1990;8:369–375. doi: 10.1097/00004872-199004000-00011. [DOI] [PubMed] [Google Scholar]
- 26.Tang EH, Leung FP, Huang Y, Feletou M, So KF, Man RY, Vanhoutte PM. Calcium and reactive oxygen species increase in endothelial cells in response to releasers of endothelium-derived contracting factor. Br J Pharmacol. 2007;151:15–23. doi: 10.1038/sj.bjp.0707190. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Dechant G. Chat in the trophic web: NGF activates Ret by Inter-RTK signaling. Neuron. 2002;33:156–158. doi: 10.1016/s0896-6273(02)00564-0. [DOI] [PubMed] [Google Scholar]
- 28.Shanks J, Manou-Stathopoulou S, Lu CJ, Li D, Paterson DJ, Herring N. Peripheral cardiac sympathetic dysfunction in the pre-hypertensive spontaneously hypertensive rat; Abstract, submitted to the Experimental Biology 2012 meeting in San Diego. [Google Scholar]
- 29.Huke S, Desantiago J, Kaetzel MA, Mishra S, Brown JH, Dedman JR, Bers DM. SR-targeted CaMKII inhibition improves SR Ca2+ handling, but accelerates cardiac remodeling in mice overexpressing CaMKIIδC. J Mol Cell Cardiol. 2011;50:230–238. doi: 10.1016/j.yjmcc.2010.10.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Albrecht MA, Colegrove SL, Friel DD. Differential regulation of ER Ca2+ uptake and release rates accounts for multiple modes of Ca2+-induced Ca2+ release. J Gen Physiol. 2002;119:211–233. doi: 10.1085/jgp.20028484. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Friel D. Interplay between ER Ca2+ uptake and release fluxes in neurons and its impact on [Ca2+] dynamics. Biol Res. 2004;37:665–674. doi: 10.4067/s0716-97602004000400024. [DOI] [PubMed] [Google Scholar]
- 32.Simmerman HK, Jones LR. Phospholamban: Protein structure, mechanism of action, and role in cardiac function. Physiol Rev. 1998;78:921–947. doi: 10.1152/physrev.1998.78.4.921. [DOI] [PubMed] [Google Scholar]
- 33.Tada M, Katz AM. Phosphorylation of the sarcoplasmic reticulum and sarcolemma. Annu Rev Physiol. 1982;44:401–423. doi: 10.1146/annurev.ph.44.030182.002153. [DOI] [PubMed] [Google Scholar]
- 34.Verkhratsky A. Endoplasmic reticulum calcium signaling in nerve cells. Biol Res. 2004;37:693–699. doi: 10.4067/s0716-97602004000400027. [DOI] [PubMed] [Google Scholar]
- 35.MacDonnell SM, Kubo H, Crabbe DL, Renna BF, Reger PO, Mohara J, Smithwick LA, Koch WJ, Houser SR, Libonati JR. Improved myocardial beta-adrenergic responsiveness and signaling with exercise training in hypertension. Circulation. 2005;111:3420–3428. doi: 10.1161/CIRCULATIONAHA.104.505784. [DOI] [PubMed] [Google Scholar]
- 36.Rizzuto R, Bernardi P, Pozzan T. Mitochondria as all-round players of the calcium game. J Physiol. 2000;529(Pt 1):37–47. doi: 10.1111/j.1469-7793.2000.00037.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Chalmers S, McCarron JG. The mitochondrial membrane potential and Ca2+ oscillations in smooth muscle. J Cell Sci. 2008;121:75–85. doi: 10.1242/jcs.014522. [DOI] [PubMed] [Google Scholar]
- 38.Bernal-Mizrachi C, Gates AC, Weng S, Imamura T, Knutsen RH, DeSantis P, Coleman T, Townsend RR, Muglia LJ, Semenkovich CF. Vascular respiratory uncoupling increases blood pressure and atherosclerosis. Nature. 2005;435:502–506. doi: 10.1038/nature03527. [DOI] [PubMed] [Google Scholar]
- 39.Ji Q, Ikegami H, Fujisawa T, Kawabata Y, Ono M, Nishino M, Ohishi M, Katsuya T, Rakugi H, Ogihara T. A common polymorphism of uncoupling protein 2 gene is associated with hypertension. J Hypertens. 2004;22:97–102. doi: 10.1097/00004872-200401000-00018. [DOI] [PubMed] [Google Scholar]
- 40.Chen L, Tian X, Song L. Biochemical and biophysical characteristics of mitochondria in the hypertrophic hearts from hypertensive rats. Chin Med J (Engl) 1995;108:361–366. [PubMed] [Google Scholar]
- 41.Buchholz J, Tsai H, Foucart S, Duckles SP. Advancing age alters intracellular calcium buffering in rat adrenergic nerves. Neurobiol Aging. 1996;17:885–892. doi: 10.1016/s0197-4580(96)00179-0. [DOI] [PubMed] [Google Scholar]
- 42.Pottorf WJ, Duckles SP, Buchholz JN. Serca function declines with age in adrenergic nerves from the superior cervical ganglion. J Auton Pharmacol. 2000;20:281–290. doi: 10.1046/j.1365-2680.2000.00194.x. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.






